Corcept Therapeutics Incorporated (NASDAQ:CORT) has been a good swing trade for us all year. I gave it to you back in August at 13.95. It made the targets a couple times currently at 28 and 29. On Thursday, it was up 1.39, or 6.26%, to 23.58, on 1.8 million shares traded. It looks like the top of the channel may be tested very shortly. It comes in at 25.
GlycoMimetics Inc (NASDAQ:GLYC), one of our swings that we gave you on September 25 when it broke out, pulled back, retested, held support, and from there it moved from 10 to 22 1/2. On Thursday, it jumped 2.10, or 11%, to 21.75, on 836,677 shares traded. The target is 26.
Remark Holdings Inc (NASDAQ:MARK) is coming out of a 4-day flag on low volume. On Thursday, it popped 99 cents, or 8%, to 13.99, on 1.5 million shares traded. The volume wasn’t huge, so I’ll reserve judgment as to how quickly it goes. If volume does pick up and it gets through 15.10, then I think the stock will go to 18 and 20.
Mirati Ther (NASDAQ:MRTX) is absolutely stellar. Ever since we put this on out on September 18 at 10.82, it has gone straight up and nearly tripled, taking into account that it was up 2.20, or 8.8%, to 27.00, on 714,612 shares traded. Soon you may see it triple at 30. It’s long in the tooth, and it’s up against resistance, but my ultimate targets would be 40 and 50.
On the long side, stocks included Digital Turbine Inc (NASDAQ:APPS), Cymabay Therapeutics, Inc. (CBAY), Catalyst Biosciences Inc (NASDAQ:CBIO), Corcept Therapeutics Incorporated (CORT), Constellium N.V (CSTM), Electro Scientific Industries Inc (NASDAQ:ESIO), Everbridge, Inc. (EVBG), Fanhua Inc. (FANH), GlycoMimetics, Inc. (GLYC), GNC Holdings, Inc. (GNC), HTG Molecular Diagnostics, Inc. (HTGM), Ichor Holdings, Ltd. (ICHR), Juno Therapeutics Inc. (JUNO), Eastman Kodak Company (KODK), Remark Holdings, Inc. (MARK), Everspin Technologies, Inc. (MRAM), Mirati Therapeutics, Inc. (MRTX), MagnaChip Semiconductor (NYSE:MX), New Age Beverages Corporation (NBEV), Neurocrine Biosciences, Inc. (NBIX), Qiwi plc (QIWI), Viking Therapeutics, Inc. (VKTX), 22nd Century Group Inc (NYSE:XXII), and Yandex N.V. (YNDX).